Lutetium Lu 177 dotatate (also known as LUTATHERA®) is a prescription nuclear medicine used in the treatment of metastatic neuroendocrine tumors, including pancreatic and small neuroendocrine tumors in the gastrointestinal tract. Once absorbed into the tumor, the radioactive material starts to break down tumor cells, destroying them.  

This treatment works differently than chemotherapy in that it targets a specific receptor in neuroendocrine tumors and is available for adult patients with low- or intermediate-grade pancreas or gastrointestinal neuroendocrine tumors.  

//--> //-->

div { background-color: rgba(245, 245, 245, 1); padding: 1rem; border-radius: 1rem; margin-block: 0.5rem; } .survivorshipevents > div p:nth-child(3) { font-size: 1.2em; font-weight: bold; font-style: italic; } .survivorshipevents > div a { background-color: rgba(2, 86, 138, 255); color: #fff; padding: 1rem; border-radius: 1rem; } .survivorshipevents > div > div { display: inline-block; } .survivorshipevents > div > div:nth-child(1) { width: 200px; vertical-align: top; margin-right: 1rem; /*-->*/

*/ /*-->*/

NJ PHORCE and CSOC Mini Symposium presents Dr.